S. Ludwig et al., 3PK, A NOVEL MITOGEN-ACTIVATED PROTEIN (MAP) KINASE-ACTIVATED PROTEIN-KINASE, IS TARGETED BY 3 MAP KINASE PATHWAYS, Molecular and cellular biology, 16(12), 1996, pp. 6687-6697
Recently we have identified a mitogen-activated protein kinase (MAPK)-
activated protein kinase, named 3pK (G. Sithanandam, F. Latif, U. Smol
a, R. A. Bernal, F.-M. Duh, H. Li, I. Kuzmin, V. Wirier, L. Geil, S. S
hresta, P. A. Lloyd, S. Bader, Y. Sekido, K. D. Tartof, V. I. Kashuba,
E. R. Zabarovsky, M. Dean, G. Klein, B. Zbar, M. I. Lerman, J. D. Min
na, U. R. Rapp, and A. Allikmets, Mel. Cell. Biol. 16:868-876, 1996).
In vitro characterization of the kinase revealed that 3pK is activated
by ERK. It was further shown that 3pK is phosphorylated in vivo after
stimulation of cells with serum. However, the in vivo relevance of th
is observation in terms of involvement of the Raf/MEK/ERK cascade has
not been established. Here we show that 3pK is activated in vivo by th
e growth inducers serum and tetradecanoyl phorbol acetate in promyeloc
ytic HL60 cells and transiently transfected embryonic kidney 293 cells
. Activation of 3pK was Raf dependent and was mediated by the Raf/MEK/
ERK kinase cascade. 3pK was also shown to be activated after stress st
imulation of cells. In vitro studies with recombinant proteins demonst
rate that in addition to ERK, members of other subgroups of the MARK f
amily, namely, p38RK and Jun-N-terminal kinases/stress-activated prote
in kinases, were also able to phosphorylate and activate 3pK. Cotransf
ection experiments as well as the use of a specific inhibitor of p38RK
showed that these in vitro upstream activators also function In vivo,
identifying 3pK as the first kinase to be activated through all three
MAPK cascades. Thus, 3pK is a novel convergence point of different MA
PK pathways and could function as an integrative element of signaling
in both mitogen and stress responses.